1326.1000 12.80 (0.97%)
NSE Jun 19, 2025 15:31 PM
Volume: 1.7M
 

ICICI Securities Limited
Revenues, EBITDA were broadly in line while net profit was higher mainly due to lower tax rate and higher other income. Adjusted for these, net profit was also almost in line with our estimates Revenues grew 7.2% YoY to | 3817.5 crore (I-direct estimate: | 3857.7 crore) as 26.8% YoY growth in Russia & other CIS to | 520 crore and 63.7% YoY growth in RoW sales to | 229.2 crore were largely offset by muted growth in the US to | 1426.5 crore EBITDA margins improved 109 bps to 19.9% (I-direct estimate:...
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
All Rapid Results
Recommended